Home › Cancro al seno triplo negativo › Virginia › Arlington
Studi clinici su Cancro al seno triplo negativo a Arlington, VA
20 studi su Cancro al seno triplo negativo cercano partecipanti presso sedi a Arlington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- Inova Schar Cancer Institute, Fairfax · a 11 mi di distanza
- NEXT Virginia, Fairfax · a 11 mi di distanza
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
In reclutamentoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
In reclutamentoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi di distanza
Study of AVZO-021 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · a 11 mi di distanza
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
In reclutamentoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
In reclutamentoFase 3
- Inova Fairfax Hospital, Fairfax · a 11 mi di distanza
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Research Site, Fairfax · a 11 mi di distanza
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
In reclutamentoFase 1
- Normunity Investigational Site, Fairfax · a 11 mi di distanza
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Clinical Trial Site, Fairfax · a 11 mi di distanza
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
In reclutamentoFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
In reclutamentoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi di distanza
A Study of LY4175408 in Participants With Advanced Cancer
In reclutamentoFase 1
- NEXT Virginia, Fairfax · a 11 mi di distanza
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
In reclutamentoFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · a 11 mi di distanza
Study of XB010 in Subjects With Solid Tumors
In reclutamentoFase 1
- Inova Schar Cancer, Fairfax · a 11 mi di distanza
- NEXT Virginia, Fairfax · a 11 mi di distanza
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
In reclutamentoFase 1
- NEXT Texas LLC - Virginia, Fairfax · a 11 mi di distanza
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
In reclutamentoFase 1
- Dren Investigational Site, Fairfax · a 11 mi di distanza
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
In reclutamentoFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · a 11 mi di distanza
Studi su Cancro al seno triplo negativo in altre città
- Houston, TX42 studi
- New York City, NY31 studi
- Nashville, TN28 studi
- Los Angeles, CA27 studi
- Boston, MA26 studi
- San Antonio, TX23 studi
- St. Louis, MO21 studi
- Atlanta, GA20 studi
- Dallas, TX18 studi
- Chicago, IL16 studi
- Columbus, OH16 studi
- Grand Rapids, MI15 studi
Altri studi a Arlington
- Cancro del polmone non a piccole cellule104 studi
- Cancro metastatico53 studi
- Cancro colorettale52 studi
- Cancro (tutti i tipi)48 studi
- Cancro al seno47 studi
- Cancro ovarico46 studi
- Cancro ai polmoni41 studi
- Cancro dell'endometrio39 studi
- Cancro pancreatico33 studi
- Carcinoma a cellule squamose della testa e del collo26 studi
- Carcinoma polmonare a piccole cellule23 studi
- Cancro dello stomaco20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.